These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 14051485)

  • 1. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AN INVESTIGATION OF THE HEMORRHAGIC DIATHESIS IN PATIENTS RECEIVING COUMARIN AND INDANEDIONE ANTICOAGULANTS.
    BAUGH CW
    Can Med Assoc J; 1965 Jan; 92(3):116-20. PubMed ID: 14232183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 4. Behaviour of factors II, VII, IX and X during long-term treatment with coumarin.
    LOELIGER EA; van der ESCH ; MATTERN MJ; den BRABANDER AS
    Thromb Diath Haemorrh; 1963 Apr; 9():74-89. PubMed ID: 13931274
    [No Abstract]   [Full Text] [Related]  

  • 5. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.
    OWREN PA; AAS K
    Scand J Clin Lab Invest; 1951; 3(3):201-8. PubMed ID: 14900966
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 7. The response of dicumarol-induced hypoprothrombinemia to vitamin K.
    REHBEIN A; JARETZKI A; HABIF DV
    Ann Surg; 1952 Apr; 135(4):454-69. PubMed ID: 14915438
    [No Abstract]   [Full Text] [Related]  

  • 8. The control of dicumarol therapy in myocardial infarction by a simple blood prothrombin test.
    MANCHESTER B; RABKIN B
    Circulation; 1954 Nov; 10(5):691-8. PubMed ID: 13209750
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoprothrombinemia in biliary fistula dogs induced by minute doses of dicumarol.
    FIELD JB
    Am J Physiol; 1952 Feb; 168(2):287-91. PubMed ID: 14903142
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 11. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THE COUMARIN ANTICOAGULANT DRUGS: A COMPARISON OF THE PHARMACODYNAMICS OF DICUMAROL AND WARFARIN IN MAN.
    O'REILLY RA; AGGELER PM; LEONG LS
    Thromb Diath Haemorrh; 1964 Apr; 11():1-22. PubMed ID: 14167102
    [No Abstract]   [Full Text] [Related]  

  • 13. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypoprothrombinemia secondary to dicoumarin therapy; shock due to prolonged vitamin K2 therapy and perfusions and spectacular cure with vitamin K1].
    SOULIER JP; SOULLARD J
    Sang; 1952; 23(8):709-14. PubMed ID: 13004931
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 17. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES.
    HELLEMANS J; VORLAT M; VERSTRAETE M
    Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of coagulation time obtained with the one-stage method according to Quick (prothrombin time) and according to Owren (prothrombin-proconvertin time) in the control of coumarin treatment].
    CLETON FJ
    Ned Tijdschr Geneeskd; 1959 Sep; 103():1835-6. PubMed ID: 13810671
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of moderate degrees of dicumarol-induced hypoprothrombinemia on experimental intravascular thrombosis.
    ROGERS JF; BARRETT RJ; LAM CR
    Surg Gynecol Obstet; 1949 Sep; 89(3):339-44. PubMed ID: 18134760
    [No Abstract]   [Full Text] [Related]  

  • 20. NATURE OF PROTHROMBIN BIOSYNTHESIS: PREPROTHROMBINAEMIA IN VITAMIN K-DEFICIENCY.
    HEMKER HC; VELTKAMP JJ; HENSEN A; LOELIGER EA
    Nature; 1963 Nov; 200():589-90. PubMed ID: 14082242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.